UNSPSC 41202006: Blastomyces dermatitidisserological reagents

In this classification, Blastomyces dermatitidis serological reagents are devices used in test to identify specific Blastomyces dermatitidis antibodies in serum. US FDA regulates Blastomyces dermatitidis serological reagents under 21 CFR 866.3060 and under FDA product code LSH.

UNSPSC 41202006 Blastomyces dermatitidis serological reagents is a Commodity code that captures state and local procurement of diagnostic testing supplies and laboratory reagents, though recent activity reflects a broader spectrum of sexually transmitted infection, HIV, syphilis, and drug-testing reagents and kits rather than the specific fungal serology the code name suggests. State and local health departments, county health and corrections departments, and municipal public health programs are the primary issuing bodies. Work being solicited includes manufacturer-specific reagent kits, control materials, calibrators, rapid test kits, and ancillary laboratory consumables for existing analyzer platforms—often tied to proprietary equipment infrastructure already in place at laboratory facilities. Illinois Department of Public Health has been the most active recent buyer, issuing multiple emergency and standard procurements for Abbott ARCHITECT i1000SR platform reagents (HIV, syphilis, and NG/NT testing supplies); the City of Austin has posted consecutive IFBs for Abbott Determine rapid HIV test kits; and Collin County, Texas has solicited offender drug-testing supplies and general laboratory services contracts.

Recent activity spans Illinois, Texas, and Georgia. Representative opportunities include the Illinois Department of Public Health change order (September 2026, IFB, due October 13, 2026) to increase NG/CT testing volumes from 15,000 to 25,000 annual tests and collection kits from 15,000 to 30,000 units under an existing Hologic platform reagent rental agreement, with the change order adding $375,000 to the five-year contract; the City of Austin IFB 9100 AAM1023 REBID (August 2026, IFB, due September 3, 2026) for approximately 375 Abbott Determine HIV test kits and 79 control kits annually; Collin County's RFP 2026-327 (September 2026, RFP, due July 23, 2026) for offender drug-testing services encompassing approximately 25,031 annual tests with laboratory certification requirements and an estimated $600,000 value; and the Illinois Department of Public Health emergency sole-source procurement (May 2026) from Abbott Laboratories for HIV and syphilis reagents, calibrators, control kits, and maintenance services totaling $38,079.50. Gwinnett County, Georgia posted an RFQ in September 2026 for drug-testing supplies compatible with an existing drugs of abuse analyzer, though minimal scope detail is available.